Hussam Shaheen, PhD, serves as the Chief Scientific Officer, Head of Research, and Senior Vice President at Paragon Therapeutics, Inc., since October 2021, with a notable previous role as Director of Antibody Discovery and Engineering at Pandion Therapeutics, a subsidiary of Merck & Co. Hussam's expertise spans several areas of biotherapeutics, including optimization of monoclonal antibodies and therapeutic proteins, alongside innovative product development and strain engineering. Prior experience includes significant contributions at Merck, where accomplishments involved leading teams and developing novel methods with pending patents. Hussam's academic background includes a Doctor of Philosophy in Biochemistry and Molecular Biology from Pennsylvania State University College of Medicine, complemented by a Bachelor of Science in Biochemistry from Texas Tech University and an International Baccalaureate from Red Cross Nordic United World College.
This person is not in any teams
This person is not in any offices